Skip to content
10-Q

Quarterly Report

VERTEX PHARMACEUTICALS INC / MA VRTX

0000875320-25-000232

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 253.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 257.6M sh
Shares Diluted Q3 2025 · Sep 30, 2025 258.6M sh
Shares Diluted Q3 2025 · Sep 30, 2024 261M sh
Shares Diluted Q3 2025 · Sep 30, 2024 258.1M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $1.89B
Stock Repurchased Q3 2025 · Sep 30, 2024 $759.2M
Capex Q3 2025 · Sep 30, 2025 $288.2M
Capex Q3 2025 · Sep 30, 2024 $205.1M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $3.13B
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$1.08B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.94B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $4.57B
Cash And Equivalents Q3 2025 · Sep 30, 2024 $5.24B
Cash And Equivalents Q3 2025 · Dec 31, 2023 $10.37B
Stockholders Equity Q3 2025 · Sep 30, 2025 $17.32B
Stockholders Equity Q3 2025 · Jun 30, 2025 $17.18B
Stockholders Equity Q3 2025 · Dec 31, 2024 $16.41B
Stockholders Equity Q3 2025 · Sep 30, 2024 $15.63B
Stockholders Equity Q3 2025 · Jun 30, 2024 $14.77B
Stockholders Equity Q3 2025 · Dec 31, 2023 $17.58B
Current Liabilities Q3 2025 · Sep 30, 2025 $4.48B
Current Liabilities Q3 2025 · Dec 31, 2024 $3.56B
Total Liabilities Q3 2025 · Sep 30, 2025 $7.54B
Total Liabilities Q3 2025 · Dec 31, 2024 $6.12B
Current Assets Q3 2025 · Sep 30, 2025 $10.57B
Current Assets Q3 2025 · Dec 31, 2024 $9.6B
Total Assets Q3 2025 · Sep 30, 2025 $24.86B
Total Assets Q3 2025 · Dec 31, 2024 $22.53B
Eps Diluted Q3 2025 · Sep 30, 2025 $4.20
Eps Diluted Q3 2025 · Sep 30, 2025 $10.68
Eps Diluted Q3 2025 · Sep 30, 2024 $4.01
Eps Diluted Q3 2025 · Sep 30, 2024 −$5.61
Eps Basic Q3 2025 · Sep 30, 2025 $4.24
Eps Basic Q3 2025 · Sep 30, 2025 $10.77
Eps Basic Q3 2025 · Sep 30, 2024 $4.05
Eps Basic Q3 2025 · Sep 30, 2024 −$5.61
Sga Expense Q3 2025 · Sep 30, 2025 $445.1M
Sga Expense Q3 2025 · Sep 30, 2025 $1.27B
Sga Expense Q3 2025 · Sep 30, 2024 $371.8M
Sga Expense Q3 2025 · Sep 30, 2024 $1.09B
Net Income Q3 2025 · Sep 30, 2025 $1.08B
Net Income Q3 2025 · Sep 30, 2025 $2.76B
Net Income Q3 2025 · Sep 30, 2024 $1.05B
Net Income Q3 2025 · Sep 30, 2024 −$1.45B
Operating Income Q3 2025 · Sep 30, 2025 $1.19B
Operating Income Q3 2025 · Sep 30, 2025 $2.97B
Operating Income Q3 2025 · Sep 30, 2024 $1.12B
Operating Income Q3 2025 · Sep 30, 2024 −$1.26B
Cost Of Revenue Q3 2025 · Sep 30, 2025 $414.8M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.19B
Cost Of Revenue Q3 2025 · Sep 30, 2024 $392.6M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.11B
Revenue Q3 2025 · Sep 30, 2025 $3.08B
Revenue Q3 2025 · Sep 30, 2025 $8.81B
Revenue Q3 2025 · Sep 30, 2024 $2.77B
Revenue Q3 2025 · Sep 30, 2024 $8.11B